Search Results - "Vinciguerra, G."

Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol ®: A prospective, controlled study by Cesarone, M.R., Belcaro, G., Rohdewald, P., Pellegrini, L., Ledda, A., Vinciguerra, G., Ricci, A., Ippolito, E., Fano, F., Dugall, M., Cacchio, M., Di Renzo, A., Hosoi, M., Stuard, S., Corsi, M.

“…The aim of this study was to evaluate the clinical efficacy of standardized French maritime pine bark extract Pycnogenol ® in patients with severe chronic…”
Get full text

Treatment of osteoarthritis with Pycnogenol®. The SVOS (San Valentino osteo-arthrosis study). evaluation of signs, symptoms, physical performance and vascular aspects by Belcaro, G, Cesarone, M.R, Errichi, S, Zulli, C, Errichi, B.M, Vinciguerra, G, Ledda, A, Renzo, A. Di, Stuard, S, Dugall, M, Pellegrini, L, Gizzi, G, Ippolito, E, Ricci, A, Cacchio, M, Cipollone, G, Ruffini, I, Fano, F, Hosoi, M, Rohdewald, P

“…The aim of this double-blind, placebo-controlled study was to evaluate the efficacy of 100 mg Pycnogenol® daily (oral capsules) in a 3 month study in patients…”
Get full text

Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon by Vinciguerra, G, Belcaro, G, Bonanni, E, Cesarone, M R, Rotondi, V, Ledda, A, Hosoi, M, Dugall, M, Cacchio, M, Cornelli, U

“…The aim of this registry study was to evaluate the effects of Pycnogenol® (French pine bark extract) on improving physical fitness (PF) in normal individuals…”
Get full text

Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol by Belcaro, G, Cesarone, M R, Errichi, S, Zulli, C, Errichi, B M, Vinciguerra, G, Ledda, A, Di Renzo, A, Stuard, S, Dugall, M, Pellegrini, L, Gizzi, G, Ippolito, E, Ricci, A, Cacchio, M, Cipollone, G, Ruffini, I, Fano, F, Hosoi, M, Rohdewald, P

“…In a previous, double-blind, placebo-controlled study we evaluated the efficacy of a 3-month treatment with Pycnogenol for 156 patients with osteoarthritis of…”
Get more information

Daily consumption of Reliv Glucaffect[trade mark sign] for 8 weeks significantly lowered blood glucose and body weight in 50 subjects by Belcaro, Gianni, Cesarone, Maria, Silvia, Errichi, Ledda, Andrea, Stuard, Stefano, G, Vinciguerra, Dougall, Mark, Cornelli, Umberto, Hastings, Carl, Schönlau, Frank

“…A public change to healthier lifestyles with more physical activity and better nutrition, including caloric restriction, is required to address the obesity…”
Get full text

Management of Superficial Vein Thrombosis and Thrombophlebitis: Status and Expert Opinion Document by Cesarone, M.R., Belcaro, G., Agus, G., Georgiev, M., Errichi, B.M., Marinucci, R., Errichi, S., Filippini, A., Pellegrini, L., Ledda, A., Vinciguerra, G., Ricci, A., Cipollone, G., Lania, M., Gizzi, G., Ippolito, E., Bavera, P., Fano, F., Dugall, M., Adovasio, R., Gallione, L., Del Boccio, G., Cornelli, U., Steigerwalt, R., Acerbi, G., Cacchio, M., Di Renzo, A., Hosoi, M., Stuard, S., Corsi, M., Di Ciano, L., Simeone, E., Collevecchio, G., Grossi, M.G., Di Giambattista, F., Carestia, F., Zukowski, A.

“…Superficial vein thrombosis is characterized by clotting of superficial veins (ie, following direct trauma) with minimal inflammatory components. Superficial…”
Get full text

Rapid Relief of Signs/Symptoms in Chronic Venous Microangiopathy With Pycnogenol®: A Prospective, Controlled Study by Cesarone, M. R., Belcaro, G., Rohdewald, P., Pellegrini, L., Ledda, A., Vinciguerra, G., Ricci, A., Gizzi, G., Ippolito, E., Fano, F., Dugall, M., Acerbi, G., Cacchio, M., Di Renzo, A., Hosoi, M., Stuard, S., Corsi, M.

“…The aim of this study was to investigate the clinical efficacy of oral Pycnogenol® (Horphag Research Ltd, UK) in patients with severe chronic venous…”
Get full text

Cramps and Muscular Pain: Prevention with Pycnogenol® in Normal Subjects, Venous Patients, Athletes, Claudicants and in Diabetic Microangiopathy by Vinciguerra, G., Belcaro, G., Cesarone, M. R., Rohdewald, P., Stuard, S., Ricci, A., Di Renzo, A., Hosoi, M., Dugall, M., Ledda, A., Cacchio, M., Acerbi, G., Fano, F.

“…The aim of this study was to assess the preventive action of Pycnogenol® (Horphag Research Ltd, UK) on cramps and muscular pain in different groups of subjects…”
Get full text

Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study by Cesarone, M R, Belcaro, G, Rohdewald, P, Pellegrini, L, Ledda, A, Vinciguerra, G, Ricci, A, Gizzi, G, Ippolito, E, Fano, F, Dugall, M, Acerbi, G, Cacchio, M, Di Renzo, A, Hosoi, M, Stuard, S, Corsi, M

“…The aim of this study was to investigate the clinical efficacy of oral Pycnogenol (Horphag Research Ltd., UK) in patients with severe chronic venous…”
Get more information

Anastomotic leaks after anterior resection for mid and low rectal cancer: survey of the Italian Society of Colorectal Surgery by Asteria, C. R., Gagliardi, G., Pucciarelli, S., Romano, G., Infantino, A., La Torre, F., Tonelli, F., Martin, F., Pulica, C., Ripetti, V., Diana, G., Amicucci, G., Carlini, M., Sommariva, A., Vinciguerra, G., Poddie, D. B., Amato, A., Bassi, R., Galleano, R., Veronese, E., Mancini, S., Pescio, G., Occelli, G. L., Bracchitta, S., Castagnola, M., Pontillo, T., Cimmino, G., Prati, U., Vincenti, R.

“…Background The aim of the survey was to assess the incidence of anastomotic leaks (AL) and to identify risk factors predicting incidence and gravity of AL…”
Get full text

Improvement of Diabetic Microangiopathy With Pycnogenol®: A Prospective, Controlled Study by Cesarone, M. R., Belcaro, G., Rohdewald, P., Pellegrini, L., Ledda, A., Vinciguerra, G., Ricci, A., Gizzi, G., Ippolito, E., Fano, F., Dugall, M., Cipollone, G., Acerbi, G., Cacchio, M., Del Boccio, G., Di Renzo, A., Stuard, S., Corsi, M.

“…The aim of this study was to investigate the clinical efficacy of oral Pycnogenol® (Horphag Research Ltd, United Kingdom) in patients with diabetic…”
Get full text

Venoruton® vs Daflon®: Evaluation of Effects on Quality of Life in Chronic Venous Insufficiency by Cesarone, M. R., Belcaro, G., Pellegrini, L., Ledda, A., Vinciguerra, G., Ricci, A., Di Renzo, A., Ruffini, I., Gizzi, G., Ippolito, E., Fano, F., Dugall, M., Acerbi, G., Cornelli, U., Hosoi, M., Cacchio, M.

“…The aim of this independent study was to investigate differences in efficacy between oxerutins (Venoruton) and 500 mg micronized diosmin + hesperidin (D+H)…”
Get full text

Pycnogenol may alleviate adverse effects in oncologic treatment by Belcaro, G, Cesarone, M R, Genovesi, D, Ledda, A, Vinciguerra, G, Ricci, A, Pellegrini, L, Gizzi, G, Ippolito, E, Dugall, M, Cacchio, M, Di Renzo, A, Stuard, S

“…A large variety of adverse reactions are well known to frequently occur during chemotherapy and radiotherapy in oncology. Specific medications exist to target…”
Get more information

Prevention of Venous Thrombosis in Long-Haul Flights with Flite Tabs: The LONFLIT-FLITE Randomized, Controlled Trial by Cesarone, M.R., Belcaro, G., Nicolaides, A.N., Ricci, A., Geroulakos, G., Ippolito, E., Brandolini, R., Vinciguerra, G., Dugall, M., Griffin, M., Ruffini, I., Acerbi, G., Corsi, M., Riordan, N.H., Stuard, S., Bavera, P., Di Renzo, A., Kenyon, J., Errichi, B.M.

“…The aim of this study was to evaluate the development of edema, and superficial and deep vein thrombosis (DVT) prophylaxis with an oral profibrinolytic agent…”
Get full text

Prevention of Recurrent Deep Venous Thrombosis with Sulodexide: The SanVal Registry by Errichi, B. M., Cesarone, M. R., Belcaro, G., Marinucci, R., Ricci, A., Ippolito, A., Brandolini, R., Vinciguerra, G., Dugall, M., Felicita, A., Pellegrini, L., Gizzi, G., Ruffini, M., Acerbi, G., Bavera, P., Di Renzo, A., Corsi, M., Scoccianti, M., Hosoi, M., Lania, M.

“…The aim of this study was to evaluate the prevention of recurrent deep vein thrombosis (RDVT) with an oral antithrombotic agent (sulodexide) in moderate to…”
Get full text

HR, 0-(Beta-Hydroxyethyl)-Rutosides; (Venoruton®): Rapid Relief of Signs/Symptoms in Chronic Venous Insufficiency and Microangiopathy: A Prospective, Controlled Study by Cesarone, M. R., Belcaro, G., Pellegrini, L., Ledda, A., Vinciguerra, G., Ricci, A., Gizzi, G., Ippolito, E., Fano, F., Dugall, M., Acerbi, G., Cacchio, M., Di Renzo, A., Stuard, S., Corsi, M.

“…The aim of this independent study was to demonstrate the rapidity of the clinical action of HR 0-(beta-hydroxyethyl)-rutosides, Venoruton® (Novartis Consumer…”
Get full text

Prevention of venous thrombosis and thrombophlebitis in long-haul flights with pycnogenol by Belcaro, G, Cesarone, M R, Rohdewald, P, Ricci, A, Ippolito, E, Dugall, M, Griffin, M, Ruffini, I, Acerbi, G, Vinciguerra, M G, Bavera, P, Di Renzo, A, Errichi, B M, Cerritelli, F

“…The aim of this study was to evaluate the occurrence of deep venous thrombosis (DVT) and superficial vein thrombosis (SVT) and its prophylaxis with an oral…”
Get more information

Prevention of Edema and Flight Microangiopathy with Venoruton ® (HR), (0-[Beta-Hydroxyethyl]Rutosides) in Patients with Varicose Veins by Cesarone, M. R., Belcaro, G., Ricci, A., Brandolini, R., Pellegrini, L., Dugall, M., Di Renzo, A., Vinciguerra, G., Gizzi, G., Cornelli, U., Errichi, B. M., Corsi, M., Ippolito, E., Adovasio, R., Cacchio, M., Stuard, S., Larnier, C., Candiani, C., Cerritelli, F.

“…The aim of this open study was the evaluation of the effects of HR (Venoruton®) at a dose of 1 g/day on the prevention and control of flight microangiopathy…”
Get full text

A Plaster Combining Diclofenac and Heparin: Microcirculatory Evaluation in 2 Models of High-Perfusion Microangiopathy by Belcaro, G., Cesarone, M. R., Vinciguerra, G., Ledda, A., Dugall, M., Di Renzo, A., Stuard, S., Ricci, A., Cacchio, M., Ippolito, E., Hosoi, M. F., Fano, P., Spignoli, G.

“…A medicated plaster containing diclofenac epolamine (DHEP) and heparin has been recently proposed for the treatment of local trauma (ie, ankle sprains)…”
Get full text

Topical Heparin: New Observations by Cesarone, M.R., Belcaro, G., Errichi, S., Cornelli, U., Pellegrini, L., Ruffini, I., Errichi, B.M., Ledda, A., Vinciguerra, G., Ricci, A., Gizzi, G., Ippolito, E., Fano, F., Dugall, M., Cacchio, M., Di Renzo, A., Hosoi, M., Grossi, M.G., Stuard, S., Corsi, M.

“…Topical effects of heparins on the skin need deeper investigations. The lack of evidence is mainly due to the lack of large investments in this field. Three…”
Get full text